Rastreamento da infecção latente por tuberculose em pacientes com artrite idiopática juvenil previamente à terapia anti‐TNF em um país de alto risco para tuberculose

Ayaz, 2010, Preventing tuberculosis in children receiving anti‐TNF treatment, Clin Rheumatol, 29, 389, 10.1007/s10067-009-1334-5 Kilic, 2012, Is it safe to use anti‐TNF‐α agents for tuberculosis in children suffering with chronic rheumatic disease, Rheumatol Int, 32, 2675, 10.1007/s00296-011-2030-8 Yasui, 2014, Immunity against Mycobacterium tuberculosis and the risk of biologic anti anti‐TNF‐α reagents, Pediatric Rheumatology, 12, 45, 10.1186/1546-0096-12-45 Bonfiglioli, 2014, LTBI screening in rheumatoid arthritis patients prior to anti‐TNF treatment in an endemic area, Int J Tuberc Lung Dis, 18, 905, 10.5588/ijtld.13.0755 Hsin, 2015, Risk of tuberculosis in children with juvenile idiopathic arthritis: a nationwide population‐based study in Taiwan, PLoS One, 10, e0128768, 10.1371/journal.pone.0128768 Sztajnbok, 2014, Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis, Pediatric Rheumatology, 12, 17, 10.1186/1546-0096-12-17 Petty, 2004, International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: second revision, Edmonton, 2001, J Rheumatol, 31, 390 Ministério da Saúde Guidelines for the control of tuberculosis in Brazil, 2011. Brasília, Brazil: Ministério da Saúde, 2011. [Acessado em maio de 2015] Disponível em: http://portal.saude.gov.br/portal/arquivos/pdf/manual_de_recomendacoes_tb.pdf Mangini, 2003, Artrite reumatoide, terapia imunossupressora e tuberculose, Rev Bras Reumatol, 43, XI, 10.1590/S0482-50042003000600002 Machado, 2001, Paediatric Rheumatology International Trials Organisation. The Brazilian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ), Clin Exp Rheumatol, 19, 25 Consolaro, 2009, Paediatric Rheumatology International Trials Organisation. Development and validation of a composite disease activity score for juvenile idiopathic arthritis, Arthritis Rheum, 61, 658, 10.1002/art.24516 van Riel, 2014, The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28), Clin Exp Rheumatol, 32, 65 Ferraz, 1990, Crosscultural reliability of the physical ability dimension of the health assessment questionnaire, J Rheumatol, 17, 813 2013 Venâncio, 2015, Incidence of tuberculosis in children in the state of São Paulo, Brazil, under spatial approach, Ciência & Saúde Coletiva, 20, 1541, 10.1590/1413-81232015205.14672014 Município de São Paulo. Boletim TB 2011. São Paulo, SP, Brazil: Município de São Paulo, 2011. [acessado em maio de 2015]. Disponível em: http://www.prefeitura.sp.gov.br/cidade/secretarias/upload/chamadas/boletim_tuberculose_2011_1335464303.pdf Ewer, 2003, Comparison of T‐cell‐based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak, Lancet, 361, 1168, 10.1016/S0140-6736(03)12950-9 Abubakar, 2013, How should I interpret gamma release assay result for tuberculosis infection, Thorax, 68, 298, 10.1136/thoraxjnl-2013-203247 Kim, 2013, Factors influencing discrepancies between the QuantiFERON‐TB Gold in Tube test and the tuberculin skin test in Korean patients with rheumatic diseases, Semin Arthritis Rheum, 42, 424, 10.1016/j.semarthrit.2012.07.001 Çanlar, 2011, Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis, Clin Rheumatol, 30, 1189, 10.1007/s10067-011-1724-3 Cruz, 2014, New approaches to diagnosing and treating latent tuberculosis in children in low‐incidence countries, Curr Opin Pediatr, 26, 106, 10.1097/MOP.0000000000000049